Inpart

🔎 What will the next 5 years look like for scientific innovation in sustainable agriculture, crop science, and alternative protein innovation? Join us for a conversation with leading experts from EIT Food and Carrot Ventures exploring current and future R&D trends aimed at sustainably feeding global populations. 📅 Mark your calendars: Wednesday, 24th July 4pm CEST / 10am EDT 👇 Don't miss out on exclusive insights from our Global Challenge campaign and secure your spot https://lnkd.in/ezzrpS27 #GlobalChallenges #techtransfer #knowledgetransfer #openinnovation #research #agritech #agriculture #sustainablefood #nutrition #sustainableagriculture #foodinnovation #foodtech #smartfarming #alternativeprotein

In this short video, Patrick Speedie, Inpart’s Chief Growth Officer, discusses what the future of R&D might look like. Watch it here: #techtransfer #knowledgeexchange #openinnovation

🌏 The agricultural sector faces mounting challenges, including climate change, food security, and sustainability. 💡 Research in agritech is vital to address these issues by developing innovative solutions that boost efficiency, productivity, and resilience in farming practices. 🌱 Learn more by reading our recent article summarizing the top 13 agritech innovations on our partnering platform, Connect Find it here: https://lnkd.in/e7Z59vpu #agritech #agritechinnovation #sustainableagriculture

Finding the right partner can be challenging. Inpart Connect, our cutting-edge matchmaking platform, connects over 6,500 academic organizations, biotechs, pharma companies, and investors. Get personalized introductions to potential partners, vetted for their intent to collaborate. Start listing your innovations on Inpart Connect and accelerate your partner discovery today! Subscribe now: https://lnkd.in/ecyV-48E

Interested in R&D trends in respiratory disease? 🫁 🔬 Download our latest R&D trends and breakthrough innovations report: https://lnkd.in/e9nXQtAa Learn more and connect with the technologies in the report, including vaccine candidates to improve immunity to emerging infectious diseases, and first-in-class anti-fibrotic small molecule therapeutics. #respiratorydisease #drugdiscovery #biopharmapartnering

Are you looking for funding to get your innovative idea off the ground? 🚀 There are a number of campaigns run by world leading R&D teams seeking emerging science and technology that may be right up your alley! 🧬 We have listed a host of current opportunities and biotech funding programs that you could take part in. 💰 Head to Labiotech and check out these campaigns now! 👇 https://lnkd.in/dpDDiHUU #biotechfunding #innovation #emergingtech #fundingopportunities #biotechprograms #researchgrants #startups #healthcareinnovation #biotechnews #lifesciences #investment

📣 Do you work in a biotech company? Share your experiences and insights on biopharma partnering to help make the process more accessible and efficient. https://lnkd.in/exVwc5Bc #biopharma #biopharmapartnering #biotech

Calling all biotech start-ups and founders: get insider info on the evaluation criteria of big pharma at the next Bayer’s Expert Monday – How does Big Pharma Evaluate Partnering Offers, on June 24 at 11 a.m. EDT/5 p.m. CEST For example, what do they look at when reviewing your pitch deck or partnering offer? Learn what’s considered a solid non-confidential deck that attracts the attention of investors and partners, such as what kind of content matters and practical tips for pitching. Join this live session and growing community of start-ups here 👇 https://lnkd.in/eQ56i3h6 #BayerExpertMondays #collaboratetocure #innovation #startups #partnerships #biotechnology #collaboration #teambayer

Inpart’s partnering network consists of over 17,000 scientists and industry decision-makers. Watch this video to hear Chloe A., Accounts Coordinator at Inpart discuss how R&D teams and academics engage in the partnering network. #techtransfer #knowledgeexchange #openinnovation

This month, we welcomed the tech transfer office at UMass Chan Medical School to our partnering platform, Inpart Connect 🌠 Available opportunities from the institute include gene therapy for glaucoma and cancer therapy response biomarkers. Find their technologies on Inpart and connect with the teams behind the innovations: https://lnkd.in/eZ_g2sQv #techtransfer #openinnovation #knowledgeexchange